| Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance AP Magiorakos, A Srinivasan, RB Carey, Y Carmeli, ME Falagas, ... Clinical microbiology and infection 18 (3), 268-281, 2012 | 13264 | 2012 |
| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... The Lancet infectious diseases 18 (3), 318-327, 2018 | 4999 | 2018 |
| Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study KK Kumarasamy, MA Toleman, TR Walsh, J Bagaria, F Butt, ... The Lancet infectious diseases 10 (9), 597-602, 2010 | 4078 | 2010 |
| Characterization of a new metallo-β-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence … D Yong, MA Toleman, CG Giske, HS Cho, K Sundman, K Lee, TR Walsh Antimicrobial agents and chemotherapy 53 (12), 5046-5054, 2009 | 3308 | 2009 |
| Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe R Cantón, M Akóva, Y Carmeli, CG Giske, Y Glupczynski, M Gniadkowski, ... Clinical microbiology and infection 18 (5), 413-431, 2012 | 1095 | 2012 |
| Clinical and economic impact of common multidrug-resistant gram-negative bacilli CG Giske, DL Monnet, O Cars, Y Carmeli Antimicrobial agents and chemotherapy 52 (3), 813-821, 2008 | 883 | 2008 |
| EUCAST expert rules in antimicrobial susceptibility testing R Leclercq, R Cantón, DFJ Brown, CG Giske, P Heisig, AP MacGowan, ... Clinical microbiology and infection 19 (2), 141-160, 2013 | 842 | 2013 |
| Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods N Johansson, M Kalin, A Tiveljung-Lindell, CG Giske, J Hedlund Clinical infectious diseases 50 (2), 202-209, 2010 | 670 | 2010 |
| Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258 B Kitchel, JK Rasheed, JB Patel, A Srinivasan, S Navon-Venezia, ... Antimicrobial agents and chemotherapy 53 (8), 3365-3370, 2009 | 663 | 2009 |
| Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective … H Grundmann, C Glasner, B Albiger, DM Aanensen, CT Tomlinson, ... The Lancet infectious diseases 17 (2), 153-163, 2017 | 631 | 2017 |
| Identification and screening of carbapenemase-producing Enterobacteriaceae P Nordmann, M Gniadkowski, CG Giske, L Poirel, N Woodford, V Miriagou, ... Clinical Microbiology and Infection 18 (5), 432-438, 2012 | 569 | 2012 |
| Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues V Miriagou, G Cornaglia, M Edelstein, I Galani, CG Giske, M Gniadkowski, ... Clinical microbiology and infection 16 (2), 112-122, 2010 | 560 | 2010 |
| The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee MJ Ellington, O Ekelund, FM Aarestrup, R Canton, M Doumith, C Giske, ... Clinical microbiology and infection 23 (1), 2-22, 2017 | 514 | 2017 |
| Global dissemination of extensively drug‐resistant carbapenemase‐producing E nterobacteriaceae: clinical perspectives on detection, treatment and infection control T Tängdén, CG Giske Journal of internal medicine 277 (5), 501-512, 2015 | 425 | 2015 |
| Escherichia coli: an old friend with new tidings J Vila, E Sáez-López, JR Johnson, U Römling, U Dobrindt, R Cantón, ... FEMS microbiology reviews 40 (4), 437-463, 2016 | 406 | 2016 |
| Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts H Grundmann, DM Livermore, CG Giske, R Canton, GM Rossolini, ... Eurosurveillance 15 (46), 2010 | 394 | 2010 |
| EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance European Committee on Antimicrobial Susceptibility Testing Version, 2013 | 383 | 2013 |
| New β-lactam–β-lactamase inhibitor combinations D Yahav, CG Giske, A Grāmatniece, H Abodakpi, VH Tam, L Leibovici Clinical microbiology reviews 34 (1), 10.1128/cmr. 00115-20, 2020 | 339 | 2020 |
| Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013 C Glasner, B Albiger, G Buist, AT Andrašević, R Canton, Y Carmeli, ... Eurosurveillance 18 (28), 20525, 2013 | 336 | 2013 |
| The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach JW Mouton, DFJ Brown, P Apfalter, R Cantón, CG Giske, M Ivanova, ... Clinical Microbiology and Infection 18 (3), E37-E45, 2012 | 324 | 2012 |
